Clinical Trials Directory

Trials / Sponsors / Venatorx Pharmaceuticals, Inc.

Venatorx Pharmaceuticals, Inc.

Industry · 8 registered clinical trials.

StatusTrialPhaseStarted
WithdrawnCefepime-taniborbactam vs Meropenem in Adults With VABP or Ventilated HABP
Ventilator-associated Pneumonia, Hospital-acquired Pneumonia
Phase 32025-06-01
CompletedSafety and Intrapulmonary Pharmacokinetics of Cefepime and Taniborbactam in Healthy Subjects
Healthy Subjects
Phase 12021-06-29
TerminatedVNRX-9945 Safety and Pharmacokinetics in Healthy Adult Volunteers
Healthy Volunteers
Phase 12021-06-23
CompletedSafety and Efficacy Study of Cefepime/VNRX-5133 in Patients With Complicated Urinary Tract Infections
Urinary Tract Infections, Acute Pyelonephritis
Phase 32019-08-07
CompletedSafety and Pharmacokinetics of VNRX-5133 in the Epithelial Lining Fluid of Healthy Adult Subjects
Healthy Subjects
Phase 12019-03-14
CompletedVNRX-5133 With VNRX-5022 in Subjects With Varying Degrees of Renal Impairment
Pharmacokinetics
Phase 12018-04-06
CompletedVNRX-5133 Drug-Drug Interaction in Healthy Adult Volunteers
Bacterial Infections
Phase 12017-10-24
CompletedVNRX-5133 SAD/MAD Safety and PK in Healthy Adult Volunteers
Bacterial Infections
Phase 12016-11-01
Venatorx Pharmaceuticals, Inc. — clinical trials (8) · Clinical Trials Directory